Patents Assigned to CRC for Biopharmaceutical Research Pty Limited
  • Method of treating nasal congestion using neuropeptide Y Y2 agonist peptides
    Patent number: 5696093
    Abstract: The invention relates to neuropeptide Y-Y.sub.2 receptor specific peptides. Preferred peptides areas follows: ##STR1## The peptides are preferably used in relieving nasal congestion.
    Type: Grant
    Filed: October 28, 1994
    Date of Patent: December 9, 1997
    Assignee: CRC for Biopharmaceutical Research Pty Limited
    Inventors: Albert Tseng, Lisa Selbie, Erica Potter